Article
Concordance Analysis of the 23-Gene Expression Signature (myPath Melanoma) With Fluorescence In Situ Hybridization Assay and Single Nucleotide Polymorphism Array in the Analysis of Challenging Melanocytic Lesions: Results From an Academic Medical Center.
The American Journal of dermatopathology - 1 Dec 2020
Castillo Stephanie A, Pham Anh K, Dagrosa Alicia T, Yan Shaofeng, Barton Dorothea T, Lefferts Joel A, Linos Konstantinos
Abstract excerpt
BACKGROUND: Fluorescence in situ hybridization (FISH) and single nucleotide polymorphism (SNP) arrays are well-established molecular tests for the analysis of challenging melanocytic lesions. A 23-gene expression signature (GES), marketed as myPath Melanoma, is a recently introduced molecular test that categorizes melanocytic lesions as "benign," "malignant," and "indeterminate." There are few studies on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.